Welcome To Nutrify Snips
Nutra News made Easy
-
The 3–1–1 Collagen Code: A Minimal Amino Acid Ratio That Drives Healthy Aging
New research reveals that the true bioactive core of collagen’s health benefits lies in a precise amino acid ratio—three glycine to one proline to one hydroxyproline. This minimal “collagen unit” was shown to extend healthspan and lifespan in C. elegans, enhance collagen homeostasis in human fibroblasts, improve strength and reduce fat accumulation in aging mice,… Read More
-
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson’s disease
The study pooled shotgun metagenomic data from multiple countries and found that Parkinson’s disease (PD) is consistently associated with higher gut microbial diversity, increased Akkermansia, and reduced SCFA-producing bacteria like Roseburia and Faecalibacterium. Functionally, PD guts showed a strong loss of microbial genes for riboflavin (B2) and biotin (B7) synthesis and reduced carbohydrate-metabolizing enzymes, indicating… Read More
-
Propolis: Nature’s Ally Against Metabolic Syndrome
Metabolic syndrome has become one of today’s most common lifestyle-related health concerns, marked by a combination of risk factors such as abdominal obesity, high blood pressure, and impaired glucose metabolism. As scientists continue to explore natural ways to manage this condition, a new study from Iran sheds light on a promising bee-derived remedy propolis.Propolis, a… Read More
-
Eurycoma longifolia Extract Improves Menopausal Quality of Life and Mood with a Strong Safety Profile and Potential for Greater Benefits at Higher Doses
Physta® (standardized Eurycoma longifolia extract) was evaluated in a 12-week randomized, double-blind, placebo-controlled trial involving 138 women aged 40–55 with menopausal symptoms. Participants received either 50 mg, 100 mg, or placebo. The 100 mg dose delivered the most meaningful effects, reducing overall MENQOL scores by 33.9 percent and improving physical and sexual domains by more… Read More
-
Arginine Emerges as a Promising Low-Cost Candidate in Alzheimer’s Research
A new study published in Neurochemistry International unveils a breakthrough in the search for safer and more accessible Alzheimer’s disease (AD) treatments. Researchers from Kindai University report that oral arginine—a naturally occurring amino acid—can effectively suppress amyloid β (Aβ) aggregation, a key driver of AD pathology. While current antibody-based therapies target Aβ, their limited effectiveness,… Read More